Abstract
Hepatitis C virus (HCV) infections occur in approximately 3% of the world population. The development of an enhanced and extensive-scale screening is required to accomplish the World Health Organization’s (WHO) goal of eliminating HCV as a public health problem by 2030. However, standard testing methods are time-consuming, expensive, and challenging to deploy in remote and underdeveloped areas. Therefore, a cost-effective, rapid, and accurate point-of-care (POC) diagnostic test is needed to properly manage the disease and reduce the economic burden caused by high case numbers. Herein, we present a fully automated reverse-transcription loop-mediated isothermal amplification (RT-LAMP)-based molecular diagnostic set-up for rapid HCV detection. The set-up consists of an automated disposable microfluidic chip, a small surface heater, and a reusable magnetic actuation platform. The microfluidic chip contains multiple chambers in which the plasma sample is processed. The system utilizes SYBR green dye to detect the amplification product with the naked eye. The efficiency of the microfluidic chip was tested with human plasma samples spiked with HCV virions, and the limit of detection observed was 500 virions/mL within 45 min. The entire virus detection process was executed inside a uniquely designed, inexpensive, disposable, and self-driven microfluidic chip with high sensitivity and specificity.
Funder
National Institutes of Health
National Science Foundation
Subject
Clinical Biochemistry,General Medicine
Reference74 articles.
1. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
2. Hepatitis Can’t Wait—WHO Commemorates World Hepatitis Day
https://www.who.int/news/item/28-07-2021-hepatitis-can-t-wait---who-commemorates-world-hepatitis-day-2021
3. Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays;Gupta;Asian J. Trans. Sci.,2014
4. Host Genetic Variants in the Pathogenesis of Hepatitis C
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献